These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37847417)

  • 21. Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in China.
    Qiao H; Tan XR; Li H; Li JY; Chen XZ; Li YQ; Li WF; Tang LL; Zhou GQ; Zhang Y; Liang YL; He QM; Zhao Y; Huang SY; Gong S; Li Q; Ye ML; Chen KL; Sun Y; Ma J; Liu N
    JAMA Oncol; 2022 Sep; 8(9):1301-1309. PubMed ID: 35834269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Systemic Inflammation and Malnutrition With Survival in Nasopharyngeal Carcinoma Undergoing Chemoradiotherapy: Results From a Multicenter Cohort Study.
    Wang X; Yang M; Ge Y; Tang M; Rao B; Chen Y; Xu H; Cong M; Guo Z; Shi H
    Front Oncol; 2021; 11():766398. PubMed ID: 34765561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between nutritional status and prognosis in advanced gastrointestinal cancer patients in palliative care: a prospective cohort study.
    Mao T; Yorke J; Zhang X; Shi Y; Wang J; Kong X; Lam KKW; Liu Q; Yang F; Ho KY
    Support Care Cancer; 2024 Oct; 32(10):697. PubMed ID: 39352564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of a comprehensive nutritional index and its correlation with quality of life and survival in patients with nasopharyngeal carcinoma undergoing IMRT: A prospective study.
    Deng J; He Y; Sun XS; Li JM; Xin MZ; Li WQ; Li ZX; Nie S; Wang C; Li YZ; Chen LP; Chen LM; Zhu SH; Li JW; Hu W; Fan YY; Guo SS; Mai HQ
    Oral Oncol; 2019 Nov; 98():62-68. PubMed ID: 31541928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.
    Peng H; Chen L; Zhang Y; Guo R; Li WF; Mao YP; Tan LL; Sun Y; Zhang F; Liu LZ; Tian L; Lin AH; Ma J
    Oncotarget; 2016 Apr; 7(17):24208-16. PubMed ID: 27008701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline Low Prognostic Nutritional Index Predicts Poor Survival in Locally Advanced Nasopharyngeal Carcinomas Treated With Radical Concurrent Chemoradiotherapy.
    Topkan E; Yucel Ekici N; Ozdemir Y; Besen AA; Mertsoylu H; Sezer A; Selek U
    Ear Nose Throat J; 2021 Feb; 100(2):NP69-NP76. PubMed ID: 31184210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma.
    Zong J; Xu H; Chen B; Guo Q; Xu Y; Chen C; Weng Y; Zheng W; Pan J; Lin S
    Radiat Oncol; 2019 Oct; 14(1):182. PubMed ID: 31640719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Treatment Advances With Survival Rates in Pediatric Patients With Nasopharyngeal Carcinoma in China, 1989-2020.
    Liang YJ; Liu LT; Li Y; Wang P; Luo MJ; Wen DX; Chen QY; Mai HQ
    JAMA Netw Open; 2022 Mar; 5(3):e220173. PubMed ID: 35234882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear overexpression of metastasis-associated protein 1 correlates significantly with poor survival in nasopharyngeal carcinoma.
    Li WF; Liu N; Cui RX; He QM; Chen M; Jiang N; Sun Y; Zeng J; Liu LZ; Ma J
    J Transl Med; 2012 Apr; 10():78. PubMed ID: 22537306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility and efficacy of chemoradiotherapy for elderly patients with locoregionally advanced nasopharyngeal carcinoma: results from a matched cohort analysis.
    Liu H; Chen QY; Guo L; Tang LQ; Mo HY; Zhong ZL; Huang PY; Luo DH; Sun R; Guo X; Cao KJ; Hong MH; Mai HQ
    Radiat Oncol; 2013 Mar; 8():70. PubMed ID: 23521779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
    Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
    Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus neoadjuvant chemotherapy plus concurrent chemoradiotherapy for ascending or descending types of nasopharyngeal carcinoma: A retrospective study.
    Lin Q; Lu L; Wang X; Lin Y; Chen Y; Chen H; Chen S; Lin S; Zhang Y; Zheng P; Chen X
    Am J Otolaryngol; 2022; 43(1):103193. PubMed ID: 34509080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic markers compared to CD3+TIL in locally advanced nasopharyngeal carcinoma.
    Al-Rajhi N; Mohammed SF; Khoja HA; Al-Dehaim M; Ghebeh H
    Medicine (Baltimore); 2021 Nov; 100(46):e27956. PubMed ID: 34797353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
    Xu YF; Ren XY; Li YQ; He QM; Tang XR; Sun Y; Shao JY; Jia WH; Kang TB; Zeng MS; Liu N; Ma J
    BMC Cancer; 2015 Apr; 15():332. PubMed ID: 25925041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma.
    Zeng X; Liu G; Pan Y; Li Y
    J Cell Mol Med; 2020 Aug; 24(15):8326-8349. PubMed ID: 32603520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum miRNAs, a potential prognosis marker of loco-regionally advanced nasopharyngeal carcinoma patients treated with CCRT.
    Zhang Z; Huang J; Wang G; Jin F; Zheng J; Xiao H; Lei L; Luo J; Chen C
    BMC Cancer; 2020 Mar; 20(1):183. PubMed ID: 32131777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low prognostic nutritional index is associated with poor outcome in middle-aged and elderly patients with non-metastatic nasopharyngeal carcinoma: a retrospective cohort study.
    Wu B; Ni LQ; Wang Y; Yang HH; Zhao SK
    Support Care Cancer; 2022 Nov; 30(11):8895-8904. PubMed ID: 35879471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment?
    Cao X; Han Y; He L; Xiang J; Wen Z
    Oral Oncol; 2011 Aug; 47(8):747-52. PubMed ID: 21665523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of nutritional impairment on treatment-related toxicity and survival in patients with nasopharyngeal carcinoma taking normal nutrition before radiotherapy.
    Su L; Lin Q; Li R; Hua Y; Zhang H; Song X; Ye J; Zhang W; Hong J
    Head Neck; 2020 Dec; 42(12):3580-3589. PubMed ID: 32851765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new prognostic histopathologic classification of nasopharyngeal carcinoma.
    Wang HY; Chang YL; To KF; Hwang JS; Mai HQ; Feng YF; Chang ET; Wang CP; Kam MK; Cheah SL; Lee M; Gao L; Zhang HZ; He JH; Jiang H; Ma PQ; Zhu XD; Zeng L; Chen CY; Chen G; Huang MY; Fu S; Shao Q; Han AJ; Li HG; Shao CK; Huang PY; Qian CN; Lu TX; Li JT; Ye W; Ernberg I; Ng HK; Wee JT; Zeng YX; Adami HO; Chan AT; Shao JY
    Chin J Cancer; 2016 May; 35():41. PubMed ID: 27146632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.